Advantage Alpha Capital Partners LP Has $5.39 Million Stock Position in Clarivate Plc (NYSE:CLVT)

Advantage Alpha Capital Partners LP cut its stake in shares of Clarivate Plc (NYSE:CLVT) by 30.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 759,171 shares of the company’s stock after selling 326,993 shares during the period. Clarivate accounts for 1.2% of Advantage Alpha Capital Partners LP’s holdings, making the stock its 29th largest position. Advantage Alpha Capital Partners LP owned about 0.11% of Clarivate worth $5,390,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently made changes to their positions in the company. Nisa Investment Advisors LLC acquired a new stake in Clarivate during the 2nd quarter worth approximately $26,000. Truist Financial Corp bought a new stake in shares of Clarivate in the second quarter valued at about $63,000. KBC Group NV boosted its position in shares of Clarivate by 33.2% in the third quarter. KBC Group NV now owns 10,225 shares of the company’s stock valued at $73,000 after acquiring an additional 2,549 shares during the period. Forum Financial Management LP acquired a new position in shares of Clarivate in the second quarter valued at about $75,000. Finally, Headlands Technologies LLC increased its position in Clarivate by 749.2% during the second quarter. Headlands Technologies LLC now owns 14,632 shares of the company’s stock worth $83,000 after acquiring an additional 12,909 shares during the period. Institutional investors own 85.72% of the company’s stock.

Insider Activity at Clarivate

In other Clarivate news, Director Saurabh Saha sold 17,646 shares of the business’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $6.75, for a total transaction of $119,110.50. Following the sale, the director now owns 23,741 shares of the company’s stock, valued at approximately $160,251.75. The trade was a 42.64 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Michael J. Angelakis purchased 1,500,000 shares of the company’s stock in a transaction dated Wednesday, November 20th. The stock was purchased at an average price of $5.11 per share, with a total value of $7,665,000.00. Following the completion of the purchase, the director now directly owns 1,500,000 shares in the company, valued at $7,665,000. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. Insiders have sold 197,646 shares of company stock valued at $1,379,111 over the last ninety days. 23.14% of the stock is owned by corporate insiders.

Clarivate Stock Performance

Shares of Clarivate stock opened at $5.74 on Tuesday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.84. The company has a market cap of $4.08 billion, a PE ratio of -2.88 and a beta of 1.18. The company has a 50 day moving average of $6.17 and a 200-day moving average of $6.11. Clarivate Plc has a 1-year low of $4.25 and a 1-year high of $9.60.

Clarivate (NYSE:CLVT) last released its earnings results on Wednesday, November 6th. The company reported $0.19 earnings per share for the quarter, hitting the consensus estimate of $0.19. Clarivate had a positive return on equity of 9.69% and a negative net margin of 50.00%. The firm had revenue of $622.20 million during the quarter, compared to analysts’ expectations of $640.81 million. During the same period in the prior year, the company earned $0.18 earnings per share. The company’s quarterly revenue was down 3.9% on a year-over-year basis. As a group, equities research analysts forecast that Clarivate Plc will post 0.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

CLVT has been the topic of a number of analyst reports. Barclays decreased their target price on shares of Clarivate from $5.00 to $4.00 and set an “underweight” rating on the stock in a research report on Thursday, November 7th. William Blair downgraded Clarivate from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada lowered their price objective on Clarivate from $7.00 to $6.00 and set a “sector perform” rating on the stock in a research note on Thursday, November 7th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $7.25.

About Clarivate

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.